Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• HC Wainwright & Co. analyst Mitchell S. Kapoor initiated coverage on Ascendis Pharma A/S (NASDAQ:ASND) with a Buy rating and announced a price target of $345. Ascendis Pharma closed at $250.25 on Wednesday. See how other analysts view this stock.
• Truist Securities analyst Miller Jump initiated coverage on DigitalOcean Holdings Inc (NYSE:DOCN) with a Buy rating and announced a price target of $175. DigitalOcean shares closed at $114.99 on Wednesday. See how other analysts view this stock.
• HC Wainwright & Co. analyst Emily Bodnar initiated coverage on Odyssey Therapeutics, Inc. (NASDAQ:ODTX) with a Buy rating and announced a price target of $44. Odyssey Therapeutics closed at $25.62 on Wednesday. See how other analysts view this stock.

Considering buying ASND stock? Here’s what analysts think:

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.